ADMA
ADMA Biologics IncHealthcare$9.19
▲ Bullish
Mkt Cap: $2.19B|Float: 233.2M|SI: 11.1%|DTC: 7.2
Data as of market close Apr 2, 2026
IV Rank
72
IV Pctl
50%
HV 20d
11454.0%
52W Range
$7-$26
ATR(14)
$1.23
Exp. Move
±15.0%
P/C Ratio
0.24
Earnings
May 6
GEX Positive
DEX Long
Net Put Premium
IV High
Max Pain Above
Exp. Move Wide
Low Put/Call
ADMA Key Options Data
- IV Rank
- 71.5%
- Total GEX
- $0.01B
- Total DEX
- $4.7M
- Max Pain
- $10.00
- Expected Move
- ±15.0%
- Put/Call OI
- 0.24
- Net Premium
- $-0.2M
- Spot Price
- $9.19
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$1.38 | ±15.0% | $7.81 | $10.56 |
| 2026-05-15 | 43 | ±$2.65 | ±28.8% | $6.54 | $11.84 |
| 2026-06-18 | 77 | ±$3.58 | ±38.9% | $5.61 | $12.76 |
| 2026-08-21 | 141 | ±$4.40 | ±47.9% | $4.79 | $13.59 |
| 2026-11-20 | 232 | ±$2.27 | ±24.8% | $6.91 | $11.46 |
| 2027-01-15 | 288 | ±$5.25 | ±57.1% | $3.94 | $14.44 |
Explore ADMA options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.